Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Microbiome Therapeutics Market Share, Size, Analysis, Growth, Forecast, Trends: By Type: Faecal Microbial Transplant, Drugs; By Application: Inflammatory Bowel Disease, Diabetes, Crohn’s Disease, Clostridium Difficile Infection, Others; Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2023-2028

Global Microbiome Therapeutics Market Outlook

The global microbiome therapeutics market size has reached a value of more than USD 159.41 million in 2021. The market is expected to grow at a CAGR of 43.60% between 2023 and 2028, reaching a value of USD 1397.77 million by 2027.

 

Global Microbiome Therapeutics Market Trends

A microbiome is a group of microorganisms living in a certain environment, and in the case of humans, this term is used for microorganisms that live in or on a body part, such as the skin or gastrointestinal tract. Microbiomes are helpful in digestion, regulating the immune system, and production of essential nutrients for blood coagulation.

 

Microbiome therapeutics are designed to alter the gut microbiome using additives, subtractive, or modulator therapy, in addition to engineered microbes, antibiotics, and other microbes to treat human disorders.

 

Rising Prevalence of Sedentary Lifestyle

People are increasingly adopting a sedentary lifestyle and busy work life, which has increased the prevalence of disorders due to lack of physical activities and lack of priority for physical well-being.

 

Growing Cases of Obesity

Due to the busy lifestyles of people and rapid urbanisation, people are shifting more and more towards packaged and junk food, which has led to a rise in obesity cases globally. The demand for microbiome therapeutics market is significantly driven by the rising cases of obesity.

 

Increasing Research and Development on Human Microbiome Therapeutics

Many microbiome-based product manufacturing companies have increased their focus on the development of therapeutics drugs with studies proving that the right combination of microbes with or without treatment processes can be beneficial in treating various disorders.

 

Global Microbiome Therapeutics Market Opportunities

Increasing Awareness for Microbiome Therapeutics as an Alternative Treatment

Growing research and developments on microbiome therapeutics and advertisement efforts have propelled the general awareness among people around the world, providing greater opportunities for the market.

 

Rising Collaborative Efforts

Public and private organisations are increasing their efforts for strategic collaborations and partnerships to launch new and innovative products.

 

Stringent Government Policies to Obstruct the Development of the Market

The regulatory requirements by current food and drug regulatory authorities are not customised for biotherapeutic products. Although regulatory organisations have authorised multiple dietary supplements that have probiotics, these products cannot be distributed for curing, mitigating, or for treatment and prevention of any diseases.

 

However, the authorities are planning changes in their ways of categorising probiotics, and this might prove to be extremely beneficial to the market expansion.

 

Global Microbiome Therapeutics Market Analysis

Based on type, the market can be segmented into faecal microbial transplants and drugs. Based on the application, it can be bifurcated into inflammatory bowel movement, diabetes, Crohn's disease, and clostridium difficile infection, among others. The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global microbiome therapeutics market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments and expansion plans.

 

  • Seres Therapeutics
  • Rebiotix, Inc
  • Enterome Bioscience
  • MaaT Pharma
  • Vedanta Biosciences, Inc.
  • AOBiome LLC
  • Others

 

Global Microbiome Therapeutics Market Types

Based on type, the market segments include faecal microbiota therapy (FMT) and drugs. Among these segments, faecal microbial transplantation, also known as stool transplantation or bacteriotherapy, has held a major share in the market. It is a procedure where healthy stool or faecal matter is collected from a healthy donor and placed in the patient’s gastrointestinal tract.

 

This segment is expected to further develop with increasing research and development for other therapeutic applications of FMT.

 

The drugs segment is expected to develop at a rapid rate during the forecast period due to increasing efforts for the development of advanced and novel drugs.

 

Global Microbiome Therapeutics Market Applications

Based on application, the market divisions include inflammatory bowel movement, diabetes, Crohn’s disease, and clostridium difficile infection, among others.

 

The clostridium difficile infection is the inflammation of the colon, which is caused by the bacteria known as clostridium difficile. This infection causes diarrhoea and colitis and results in the disruption of normal and healthy bacteria in the colon.

 

This segment is expected to experience significant growth due to the increasing use of faecal microbiota transplants (FMT) in the treatment of Clostridium difficile.

 

Crohn’s disease is a type of bowel inflammatory disease that affects the lining of a human’s digestive tract. This disease can cause abdominal pain, diarrhoea, weight loss, and anaemia. This segment is expected to go through an extensive growth with the use faecal microbiota transplantation for treatment.

 

Competitive Landscape

Seres Therapeutics is an American-based clinical-stage therapeutics company, which was founded in 2010. Their focus lies in the development of therapeutic products and novel drugs for the treatment of diseases by targeting the human microbiome.

 

Rebiotix, Inc. is a biotechnology company working around clinical-stage procedures and products, and it is based in the United States and founded in 2011. The company focuses on biotechnology research for the development of microbiome-based therapeutics including human microbiome, microbiota restoration therapy, and clostridioides difficile infection. The Rebiotix company is a part of the Ferring Pharmaceuticals company.

 

Enterome Bioscience is a clinical-stage biopharmaceutical company specialising in immune-oncology, auto-immunity, inflammatory bowel diseases, microbiomes, metagenomics, and immunotherapies. Their company is headquartered in France, and it was founded in 2011. They have developed highly promising products, focusing on cancer and auto-immune diseases including OncoMimics and EndoMimics.

 

Other market players include MaaT Pharma, Vedanta Biosciences, Inc., and ABiome LLC, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • Region
Breakup by Type
  • Faecal Microbial Transplant
  • Drugs
Breakup by Application
  • Inflammatory Bowel Disease
  • Diabetes
  • Crohn’s Disease
  • Clostridium Difficile Infection
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Seres Therapeutics
  • Rebiotix, Inc
  • Enterome Bioscience
  • MaaT Pharma
  • Vedanta Biosciences, Inc.
  • AOBiome LLC
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Microbiome Therapeutics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Microbiome Therapeutics Historical Market (2018-2022) 
    8.3    Global Microbiome Therapeutics Market Forecast (2023-2028)
    8.4    Global Microbiome Therapeutics Market by Type
        8.4.1    Faecal Microbial Transplant
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Microbiome Therapeutics Market by Application
        8.5.1    Inflammatory Bowel Disease
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Diabetes
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Crohn’s Disease
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Clostridium Difficile Infection
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Others
    8.6    Global Microbiome Therapeutics Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022) 
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022) 
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022) 
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022) 
            8.6.4.3    Forecast Trend (2023-2028)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2022) 
            8.6.5.3    Forecast Trend (2023-2028)
9    North America Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Seres Therapeutics
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Rebiotix, Inc
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Enterome Bioscience
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    MaaT Pharma
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Vedanta Biosciences, Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    AOBiome LLC
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Microbiome Therapeutics Market: Key Industry Highlights, 2018 and 2028
2.    Global Microbiome Therapeutics Historical Market: Breakup by Type (USD Million), 2018-2022
3.    Global Microbiome Therapeutics Market Forecast: Breakup by Type (USD Million), 2023-2028
4.    Global Microbiome Therapeutics Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Microbiome Therapeutics Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Microbiome Therapeutics Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Microbiome Therapeutics Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Microbiome Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Microbiome Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Microbiome Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Microbiome Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Microbiome Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Microbiome Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Microbiome Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Microbiome Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Microbiome Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Microbiome Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Microbiome Therapeutics Market Structure
 

Key Questions Answered in the Report

In 2021, the global market for microbiome therapeutics reached a size of USD 159.41 million.

The market is expected to grow at a CAGR of 43.60% during the period 2023-2028.

The market is expected to reach a value of USD 1397.77 million.

The market is driven by the rising prevalence of sedentary lifestyles leading to increased cases of obesity and increasing research and development for human microbiome therapeutics.

Growing adoption of packed and fast foods in the diets of people and increasing awareness of microbiome therapeutics for gut disorders are among key trends driving the market growth.

The regional markets include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The products in the market include faecal microbial transplants and drugs.

The applications available in the market include inflammatory bowel movement, diabetes, Crohn's disease, and clostridium difficile infection, among others.

The key players in the market include Seres Therapeutics, Rebiotix, Inc, Enterome Bioscience, MaaT Pharma, Vedanta Biosciences, Inc., and AOBiome LLC, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER